drugset / Trial / NCT02473016
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
CrossoverSingle-blindTreatment
Summary
A placebo-controlled, single-blind study to evaluate the safety and preliminary efficacy of nasal carbon dioxide for the symptomatic treatment of classical trigeminal neuralgia.
Timeline
- Start
- 2015-09
- Primary completion
- 2017-03
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carbon dioxide | Other / unclassified | — | Intranasal |